COVID-19
COVID-19 has shifted attention away from major health challenges like non-communicable diseases, notably cancer and obesity
ASOI
Statement from the Association for the Study of Obesity in Ireland
We understand that people living with obesity and their families are very concerned and worried about Covid-19. Unfortunately, many recent media reports have added to that concern, by including unreliable and misleading information…
Lancet Diabetes Endocrinol 2020
Bariatric and metabolic surgery during and after the COVID-19 pandemic
The coronavirus disease 2019 pandemic is wreaking havoc on society, especially health-care systems, including disrupting bariatric and metabolic surgery. The current limitations on accessibility to non-urgent care undermine postoperative monitoring of patients who have undergone such operations.
EASO
Compromise amendment passes with an overwhelming majority
EASO (European Association for the Study of Obesity) are delighted to receive confirmation that a compromise amendment (CA 10) listing obesity as a chronic disease within the EU4Health proposal, voted by the ENVI Committee (The Committee on the Environment, Public Health and Food Safety) on 14 October, passed with an overwhelming majority:
Childhood Obesity Task Force
Obesity patients must not be ‘stigmatised’ in re-start of non-COVID health treatments
The Irish Society for Clinical Nutrition and Metabolism (IrSPEN) said that patients with obesity are at higher risk of complications from COVID-19 – and need equal access to treatments as the health system begins to address backlogs and schedule new appointments….